These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 2567178)

  • 1. Antagonism of moderate degrees of vecuronium-induced neuromuscular block by small doses of neostigmine.
    Johnson RA; Harper NJ
    Br J Anaesth; 1989 May; 62(5):483-7. PubMed ID: 2567178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Time to peak effect of neostigmine at antagonism of atracurium- or vecuronium-induced neuromuscular block.
    Kirkegaard-Nielsen H; Helbo-Hansen HS; Lindholm P; Severinsen IK; Bülow K
    J Clin Anesth; 1995 Dec; 7(8):635-9. PubMed ID: 8747561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of neostigmine in the antagonism of residual neuromuscular blockade produced by vecuronium.
    Jones JE; Hunter JM; Utting JE
    Br J Anaesth; 1987 Nov; 59(11):1454-8. PubMed ID: 2891365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose-response relationships for neostigmine antagonism of vecuronium-induced neuromuscular block in adults and the elderly.
    McCarthy GJ; Cooper R; Stanley JC; Mirakhur RK
    Br J Anaesth; 1992 Sep; 69(3):281-3. PubMed ID: 1356398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recovery from vecuronium neuromuscular blockade following neostigmine administration in infants, children, and adults during halothane anesthesia.
    Debaene B; Meistelman C; d'Hollander A
    Anesthesiology; 1989 Dec; 71(6):840-4. PubMed ID: 2574016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conditions to optimise the reversal action of neostigmine upon a vecuronium-induced neuromuscular block.
    Baurain MJ; Dernovoi BS; D'Hollander AA; Hennart DA; Cantraine FR
    Acta Anaesthesiol Scand; 1996 May; 40(5):574-8. PubMed ID: 8792887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antagonism of vecuronium-induced neuromuscular blockade with edrophonium or neostigmine.
    Mirakhur RK; Gibson FM; Lavery GG
    Br J Anaesth; 1987 Apr; 59(4):473-7. PubMed ID: 2882768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antagonism of vecuronium-induced neuromuscular block in patients pretreated with magnesium sulphate: dose-effect relationship of neostigmine.
    Fuchs-Buder T; Ziegenfuss T; Lysakowski K; Tassonyi E
    Br J Anaesth; 1999 Jan; 82(1):61-5. PubMed ID: 10325838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose-response relationships for neostigmine antagonism of rocuronium-induced neuromuscular block in children and adults.
    Abdulatif M; Mowafi H; al-Ghamdi A; el-Sanabary M
    Br J Anaesth; 1996 Dec; 77(6):710-5. PubMed ID: 9014620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antagonism of vecuronium and atracurium: comparison of neostigmine and edrophonium administered at 5% twitch height recovery.
    Caldwell JE; Robertson EN; Baird WL
    Br J Anaesth; 1987 Apr; 59(4):478-81. PubMed ID: 2882769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversal of residual neuromuscular block with neostigmine at one to four hours after a single intubating dose of vecuronium.
    Caldwell JE
    Anesth Analg; 1995 Jun; 80(6):1168-74. PubMed ID: 7762847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can early administration of neostigmine, in single or repeated doses, alter the course of neuromuscular recovery from a vecuronium-induced neuromuscular blockade?
    Magorian TT; Lynam DP; Caldwell JE; Miller RD
    Anesthesiology; 1990 Sep; 73(3):410-4. PubMed ID: 1975484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors affecting neostigmine reversal of vecuronium block during sevoflurane anaesthesia.
    Morita T; Kurosaki D; Tsukagoshi H; Shimada H; Sato H; Goto F
    Anaesthesia; 1997 Jun; 52(6):538-43. PubMed ID: 9203879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antagonism of blockade produced by atracurium or vecuronium with low doses of neostigmine.
    Jones JE; Parker CJ; Hunter JM
    Br J Anaesth; 1988 Nov; 61(5):560-4. PubMed ID: 2905146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antagonism of vecuronium-induced neuromuscular block.
    Bentley JB; Lahet BS
    Anesthesiology; 1991 Jun; 74(6):1169-70. PubMed ID: 1675041
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of recovery following rapacuronium, with and without neostigmine, and succinylcholine.
    Hayes A; Breslin D; Reid J; Mirakhur RK
    Anaesthesia; 2000 Sep; 55(9):859-63. PubMed ID: 10947748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is recovery of neuromuscular transmission complete after the use of neostigmine to antagonize block produced by rocuronium, vecuronium, atracurium and pancuronium?
    Baurain MJ; Hoton F; D'Hollander AA; Cantraine FR
    Br J Anaesth; 1996 Oct; 77(4):496-9. PubMed ID: 8942335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimum time for neostigmine administration to antagonize vecuronium-induced neuromuscular blockade.
    Kirkegaard-Nielsen H; Toft P; Severinsen IK; May O
    Eur J Anaesthesiol; 1995 Nov; 12(6):585-9. PubMed ID: 8665881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neostigmine reversal of vecuronium neuromuscular block and the influence of renal failure.
    Dhonneur G; Rebaine C; Slavov V; Ruggier R; De Chaubry V; Duvaldestin P
    Anesth Analg; 1996 Jan; 82(1):134-8. PubMed ID: 8712389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of atropine dose on recovery from vecuronium-induced neuromuscular blockade.
    Baurain MJ; Dernovoi BS; d'Hollander AA; Barvais L
    Anesthesiology; 1992 Jul; 77(1):17-20. PubMed ID: 1351705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.